During Wednesday's "Mad Money," Jim Cramer talked about speculative stocks and blue-chip stocks and mentioned Pfizer (PFE) , which reported positive vaccine trial data that boosted shares by 3.1%. Let's check out blue-chip Pfizer.
More from Investing
Be cautious if considering this stock, the bullish case is not clear.
Given there is little price history as yet, things are looking positive so far for sustainable building products firm, AZEK.
With Sino-U.S. relations approaching an all-time low, trade negotiators will chat by video link in an attempt to get the "Phase 1" deal back on track.
The charts of the provider of call center software indicate a longer-term price target well above its current price.